Clinical study of 99mTc-Rituximab combined with dyes double tracing for axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer

Background and objectiveWhether sentinel lymph node biopsy (SLNB) after neoadjuvant chemotherapy (NAC) for breast cancer is an alternative to axillary lymph node dissection (ALND) remains controversial. In this study, the results of SLNB performed with 99mTc-Rituximab combined with dyes were analyze...

Повний опис

Бібліографічні деталі

Автори:	Minxue Zhuang, Yidan Lin, HongBin Qiu, Wei Chen, Ruo Wang, HuanHong Zeng, Mengbo Lin, Hui Zhang
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2025-08-01
Серія:	Frontiers in Oncology
Предмети:	breast cancer neoadjuvant chemotherapy (NAC) sentinel lymph node biopsy (SLNB) 99mTc-Rituximab axillary lymph node dissection (ALND)
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1568550/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!